COVID-19: You can find information and stay up-to-date on the latest support for business on our coronavirus page or by calling 13 28 46.×

You are here:

If you are a new applicant or existing grantee and have been impacted by COVID-19 or a natural disaster, please contact your Customer Service Manager or one of the agents at our Contact Centre to discuss your circumstances and how we can assist you.

You can find more information and support on our Emergency management page.

Medical Research Future Fund – Preventive and Public Health Research Initiative – 2020 Targeted Translation Research Accelerator Grant Opportunity


The 2020 Targeted Translation Research Accelerator Grant Opportunity will provide an organisation with funding to deliver the Accelerator as a comprehensive package of activities to improve outcomes for diabetes and cardiovascular disease.
Closed

What do you get?

The maximum grant amount is $47 million.

Who is this for?

Eligible organisations seeking to deliver the Accelerator.

Overview


The 2020 Targeted Translation Research Accelerator Grant Opportunity was announced as part of the Medical Research Future Fund and is an Initiative under the Preventive and Public Health Research Initiative.

The objective of the grant opportunity is to support the development of novel preventive, diagnostic and therapeutic approaches and products for diabetes and cardiovascular disease.

To achieve this objective an organisation will be funded to deliver the Accelerator as a comprehensive package of activities to improve outcomes for diabetes and cardiovascular disease.

Governance for the implementation of this project by the organisation will be provided by a board of experts appointed by the Minister for Health.

The successful independent organisation will be responsible for ensuring that the Accelerator:

  • establishes through competitive processes two research centres, one for diabetes and one for cardiovascular disease to accelerate therapies for the prevention, early detection and treatment of disease related complications
  • supports through competitive processes research projects on the potential common pathways interactions, and complexities for patients experiencing two or more of the following: Type 1 diabetes; Type 2 diabetes; and cardiovascular disease
  • targets investment and related support through partnership projects to progress promising drug and device development projects, with a focus on promoting commercialisation of novel therapeutics and devices for diabetes and cardiovascular disease
  • sources, nurtures and invests in early stage therapeutic research targets to transform diagnostic and therapeutic care for people with diabetes
  • commissions and conducts research to support the health and commercial sectors to deliver transformations in diabetes and cardiovascular disease.

The expected outcome of the research funded through partnership projects with the independent organisation selected under the grant opportunity is to improve knowledge and its translation into practice in order to reduce the burden of diabetes and cardiovascular disease.

Eligibility


What are the eligibility criteria?

To be eligible you must:

  • have an Australian Business Number (ABN)
  • be incorporated in Australia

and in accordance with s20 and s24 of the Medical Research Future Fund Act 2015, be one of the following entities:

  • a medical research institute
  • a university
  • a corporate Commonwealth entity
  • a corporation (including businesses and not for profits)
  • a state or territory government entity.

Joint applications are encouraged, provided you have a lead organisation who is the main driver of the project and is eligible to apply.

We cannot waive the eligibility criteria under any circumstances.

Applying


How do you apply?

The 2020 Targeted Translation Research Accelerator Grant Opportunity is currently closed to applications.

  • Need help?

  • Contact us for help with your application or to find out more.

  • Monday – Friday, 8am – 8pm across Australia

Key documents


Grant opportunity guidelines

Sample application form

Sample grant agreement - standard

Board and CEO letter